Shire whistleblower awarded $5.9 million in FCA settlement
Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said last week.
The allegations were contained in two lawsuits filed under the False Claims Act’s whistleblower provisions by a former Shire executive and former Shire sales representatives.… Continue Reading